Avi Maimon

12 papers receiving 398 citations

Hit Papers

p16-dependent increase of PD-L1 stability regulates immunosurveillance of senescent cells 2024 · 51 citations
512024202620251020304050

Peers

Avi Maimon
Comparison fields: 5 of 61
  • Immunology 188
  • Cancer Research 55
  • Molecular Biology 198
  • Physiology 66
  • Aging 4
Replace Kazuhito Gotoh with:
Kazuhito Gotoh Japan
Christine Quach United States
Hengxiao Ni China
Catherine Olesch Germany
Clément Oyeniran United States
Xuelian Hu China
Chinky Shiu Chen Liu India
Delin Kong China
Avi Maimon relative to Kazuhito Gotoh Japan Kazuhito Gotoh's profile →
Citations per field
00.5×1.5×2.2×
Kazuhito Gotoh · 1×
Citations per year

Countries citing papers authored by Avi Maimon

Since Specialization
Citations

This map shows the geographic impact of Avi Maimon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avi Maimon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avi Maimon more than expected).

Fields of papers citing papers by Avi Maimon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avi Maimon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avi Maimon. The network helps show where Avi Maimon may publish in the future.

Co-authors

The 25 scholars most cited alongside Avi Maimon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Avi Maimon Line = papers co-authored together Avi Maimon links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1 201298
2 201978
3 202154
4
p16-dependent increase of PD-L1 stability regulates immunosurveillance of senescent cells
Hit paper breakdown →
202451
5 201848
6 201732
7 202428
8 20226
9 20243
10 20242
11 20251
12 20251

About Avi Maimon

Avi Maimon is a scholar working on Immunology, Cancer Research, Molecular Biology, Computational Theory and Mathematics and Pulmonary and Respiratory Medicine, having authored 12 papers that have together received 402 indexed citations. Recurring topics across this work include Phagocytosis and Immune Regulation (4 papers), RNA modifications and cancer (3 papers), Ferroptosis and cancer prognosis (3 papers), Computational Drug Discovery Methods (2 papers), interferon and immune responses (1 paper), Single-cell and spatial transcriptomics (1 paper), Protein Degradation and Inhibitors (1 paper) and Osteoarthritis Treatment and Mechanisms (1 paper). The work is most often cited by research in Immunology (188 citations), Cancer Research (55 citations), Molecular Biology (198 citations), Physiology (66 citations) and Aging (4 citations). Avi Maimon has collaborated with scholars based in Israel, Germany and United States. Frequent co-authors include Tal Burstyn‐Cohen, Ben Davidson, Rotem Karni, Adrian R. Krainer, Zahava Siegfried, Shivam Priya, Sagie Schif‐Zuck, Amiram Ariel, Stuart L. Fischman and Rakefet Czerninski. Their work appears in journals such as Frontiers in Immunology, Advanced Science, iScience, Nature Cell Biology and Cell Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026